Browsing by Author GlaxoSmithKline plc.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 14 of 14
Issue DateTitleAuthor(s)
30-Oct-2006Association between HSV-2 and HIV-1 viral load in semen, cervico-vaginal secretions and genital ulcers of Thai men and womenKathryn Chu; Sukhum Jiamton; Jacques Pepin; Frances Cowan; Bussakorn Mahakkanukrauh; Ruengpung Suttent; Noah J. Robinson; Sylvie Deslandes; Eric Frost; Pongsakdi Chaisilwattana; Puan Suthipinittharm; Heiner Grosskurth; David Brown; Shabbar Jaffar; London School of Hygiene & Tropical Medicine; Mahidol University; Universite de Sherbrooke; UCL; GlaxoSmithKline plc.; Medical Research Council Programme on AIDS in Uganda; Health Protection Agency
1-Jun-2001Clinical trial of halofantrine with modified doses for treatment of malaria in the hospital for tropical diseasesSrivicha Krudsood; Pratap Singhasivanon; Udomsak Silachamroon; Sombat Treeprasertsuk; Wongphan Kaivipakbanyai; Kobsiri Chalermrut; Nuntaporn Phophak; John Horton; Dennis Kyle; Sornchai Looareesuwan; Mahidol University; GlaxoSmithKline plc.; Armed Forces Research Institute of Medical Sciences, Thailand
3-Jan-2014Corrigendum to "Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated japanese encephalitis sa 14-14-2 vaccine in philippine infants" [vaccine 26 (2008) 2234-2241]John C. Victor; Salvacion Gatchalian; Yafu Yao; Benli Zhou; Lei Zhang; Sutee Yoksan; Mansour Yaïch; Kathleen M. Neuzil; PATH Seattle; Gokila; Chengdu Institute of Biological Products; Mahidol University; PATH; GlaxoSmithKline plc.
20-Feb-2017Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)(Clin Transl Allergy (2016) 6 (29) DOI: 10.1186/s13601-016-0116-9)J. Bousquet; J. Farrell; G. Crooks; P. Hellings; E. H. Bel; M. Bewick; N. H. Chavannes; J. Correia De Sousa; A. A. Cruz; T. Haahtela; G. Joos; N. Khaltaev; J. Malva; A. Muraro; M. Nogues; S. Palkonen; S. Pedersen; C. Robalo-Cordeiro; B. Samolinski; T. Strandberg; A. Valiulis; A. Yorgancioglu; T. Zuberbier; A. Bedbrook; W. Aberer; M. Adachi; A. Agusti; C. A. Akdis; M. Akdis; J. Ankri; A. Alonso; I. Annesi-Maesano; I. J. Ansotegui; J. M. Anto; S. Arnavielhe; H. Arshad; C. Bai; I. Baiardini; C. Bachert; A. K. Baigenzhin; C. Barbara; E. D. Bateman; B. Beghé; A. Ben Kheder; K. S. Bennoor; M. Benson; K. C. Bergmann; T. Bieber; C. Bindslev-Jensen; L. Bjermer; H. Blain; F. Blasi; A. L. Boner; M. Bonini; S. Bonini; S. Bosnic-Anticevitch; L. P. Boulet; R. Bourret; P. J. Bousquet; F. Braido; A. H. Briggs; C. E. Brightling; J. Brozek; R. Buhl; P. G. Burney; A. Bush; F. Caballero-Fonseca; D. Caimmi; M. A. Calderon; CHU Montpellier; MACVIA-LR; Vieillissement et Maladies Chroniques. Approches Epidemiologiques et de Sante Publique; Universite de Versailles Saint-Quentin-en-Yvelines; Department of Health; National Health Service; KU Leuven; European Academy of Allergy and Clinical Immunology; Academic Medical Centre, University of Amsterdam; European Respiratory Society; iQ4U Consultants Ltd; Leiden University Medical Center - LUMC; Global Alliance Against Chronic Respiratory Diseases (GARD); International Primary Care Respiratory Group; Universidade do Minho, Escola de Ciências da Saúde; Universidade Federal da Bahia; GARD Executive Committee; EIP on AHA Commitment for Action; Skin and Allergy Hospital; University Hospital of Ghent; Universidade de Coimbra, Faculdade de Medicina; AgeingatCoimbra Reference Site; Azienda Ospedaliera Di Padova; Caisse Assurance Retraite et Santé Au Travail Languedoc-Roussillon (CARSAT-LR); EFA European Federation of Allergy and Airways Diseases Patients' Associations; Syddansk Universitet; Centro Hospitalar e Universitário de Coimbra; Medical University of Warsaw; Helsingin Yliopisto; Oulun Yliopisto; European Union; Vilniaus universitetas; European Academy of Paediatrics (EAP/UEMS-SP); Celal Bayar Üniversitesi; Turkish Thoracic Society; Charité – Universitätsmedizin Berlin; Secretary General of the Global Allergy and Asthma European Network (GA2LEN); Medizinische Universität Graz; International University of Health and Welfare; Universitat de Barcelona; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias; University of Zurich; Inserm; Clinica Quiron; Centre for Research in Environmental Epidemiology (CREAL); Hospital del Mar; CIBER Epidemiología Y Salud Pública; Universitat Pompeu Fabra Barcelona; Digi Health; David Hide Asthma and Allergy Research Centre; Chinese Medical Association; Ospedale Policlinico San Martino; EuroAsian Respiratory Society; Faculdade de Medicina, Universidade de Lisboa; University of Cape Town; Università degli Studi di Modena e Reggio Emilia; Universite de Tunis El Manar, Hopital Abderrahmene Mami; National Institute of Diseases of the Chest and Hospital; Linköpings universitet; Universität Bonn; Odense Universitetshospital; Skånes universitetssjukhus; Centre Européen de Recherche sur le Mouvement Humain, Université de Montpellier; Università degli Studi di Milano; Università degli Studi di Verona; Università degli Studi di Roma La Sapienza; Università degli Studi della Campania Luigi Vanvitelli; The University of Sydney; Université Laval; University of Glasgow; University Hospitals of Leicester NHS Trust; University of Leicester; McMaster University, Faculty of Health Sciences; Johannes Gutenberg Universität Mainz; National Heart and Lung Institute; GlaxoSmithKline plc.; Medical Research Council; Royal Brompton Hospital; Centro Medico Docente La Trinidad; University of Liverpool; Universidade Federal de Minas Gerais; Région Languedoc Roussillon; Oslo University Hospital; Allergy & Asthma Associates of Southern California; Regional Ministry of Equality; University of South Florida, Tampa; Universidad Simón Bolívar; Asma e Immunologia; Panepistimio Kritis; Capital Institute of Pediatrics; Tbilisi State Medical University; Pulmonolory Research Institute FMBA; Latvian Psychiatric Association; Nova Southeastern University; Imperial College London; Karolinska Institutet; Technical University of Munich; CHU Strasbourg; EUREGHA; University of Edinburgh; Universitatea de Medicina si Farmacie Iuliu Hatieganu din Cluj-Napoca; Kronikgune; Sorbonne Universite
1-Oct-2007Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug developmentErnest Beutler; Stephan Duparc; Ogobara Doumbo; Kanjaksha Ghosh; Marcus Vinicius Guimaraes De Lacerda; Didier Lapierre; Sornchai Looareesuwan; Zulfiqarali Premji; Tom Vulliamy; Christopher Whitty; Scripps Research Institute; International Center Cointrin; University of Bamako Faculty of Medicine, Pharmacy and Odonto-Stomatology; Institute of Immunohaematology Mumbai; Fundacao de Medicina Tropical do Amazonas; GlaxoSmithKline plc.; Mahidol University; University of Dar Es Salaam; Imperial College London; London School of Hygiene & Tropical Medicine
1-Jan-2015Performance of binaxNOW G6PD deficiency point-of-care diagnostic in P. vivax-infected subjectsLyda Osorio; Nick Carter; Preetam Arthur; Germana Bancone; Sowmya Gopalan; Sandeep K. Gupta; Harald Noedl; Sanjay K. Kochar; Dhanpat K. Kochar; Srivicha Krudsood; Marcus V. Lacerda; Alejandro Llanos-Cuentas; Ronnatrai Rueangweerayut; Ramadurai Srinivasan; Moritz Treiber; Jörg J. Möhrle; Justin Green; Universidad del Valle, Cali; GlaxoSmithKline plc.; Sri Ramachandra Medical College & Research Institute (Deemed University); Shoklo Malaria Research Unit; MV Hospital and Research Centre; Medizinische Universitat Wien; Sardar Patel Medical College; University of Rajasthan; Mahidol University; Fundacao de Medicina Tropical do Amazonas; Universidad Peruana Cayetano Heredia; Mae Sot General Hospital; Clinical Development
1-Dec-1999Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in ThailandDouglas S. Walsh; Sornchai Looareesuwan; Polrat Wilairatana; D. Gray Heppner; Douglas B. Tang; Thomas G. Brewer; Watcharee Chokejindachai; Parnpen Viriyavejakul; Dennis E. Kyle; Wilbur K. Milhous; Brian G. Schuster; John Horton; David J. Braitman; Ralf P. Brueckner; Mahidol University; Walter Reed Army Institute of Research; U.S. Army Medical Materiel Development Activity; GlaxoSmithKline plc.
1-Nov-2017A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malariaMark M. Fukuda; Srivicha Krudsood; Khadeeja Mohamed; Justin A. Green; Sukhuma Warrasak; Harald Noedl; Ataya Euswas; Mali Ittiverakul; Nillawan Buathong; Sabaithip Sriwichai; R. Scott Miller; Colin Ohrt; Armed Forces Research Institute of Medical Sciences, Thailand; Mahidol University; GlaxoSmithKline plc.; Walter Reed Army Institute of Research; Medizinische Universitat Wien; Bangkok Hospital Medical Center; Bill and Melinda Gates Foundation; Consortium for Health Action
1-Jun-2016Replication and characterization of association between ABO SNPs and red blood cell traits by meta-analysis in EuropeansStela McLachlan; Claudia Giambartolomei; Jon White; Pimphen Charoen; Andrew Wong; Chris Finan; Jorgen Engmann; Tina Shah; Micha Hersch; Clara Podmore; Alana Cavadino; Barbara J. Jefferis; Caroline E. Dale; Elina Hypponen; Richard W. Morris; Juan P. Casas; Meena Kumari; Yoav Ben-Shlomo; Tom R. Gaunt; Fotios Drenos; Claudia Langenberg; Diana Kuh; Mika Kivimaki; Rico Rueedi; Gerard Waeber; Aroon D. Hingorani; Jacqueline F. Price; Ann P. Walker; Jackie Cooper; Ian N. Day; Maneka De Silva; Frank Dudbridge; Ghazaleh Fatemifar; Victoria Garfield; Steve E. Humphries; Debbie A. Lawlor; Teri Louise Davies; Vincent Plagnol; Christine Power; Sonia Shah; Reecha Sofat; Daniel I. Swerdlow; Philippa J. Talmud; Peter Whincup; John C. Whittaker; Delilah Zabaneh; University of Edinburgh; Icahn School of Medicine at Mount Sinai; UCL; London School of Hygiene & Tropical Medicine; Mahidol University; Universitat Lausanne Schweiz; Swiss Institute of Bioinformatics; University of Cambridge; Barts and The London School of Medicine and Dentistry; UCL Institute of Child Health; University of South Australia; South Australian Health and Medical Research Institute; University of Bristol; Institute for Social and Economic Research, University of Essex; Centre Hospitalier Universitaire Vaudois; University of London; GlaxoSmithKline plc.
29-Mar-2013Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: A workshop reportLorenz Von Seidlein; Sarah Auburn; Fe Espino; Dennis Shanks; Qin Cheng; James McCarthy; Kevin Baird; Catherine Moyes; Rosalind Howes; Didier Ménard; Germana Bancone; Ari Winasti-Satyahraha; Lasse S. Vestergaard; Justin Green; Gonzalo Domingo; Shunmay Yeung; Ric Price; Menzies School of Health Research; Gokila; Australian Army Malaria Institute; University of Queensland; Eijkman-Oxford Clinical Research Unit; University of Oxford; Institut Pasteur du Cambodge; Shoklo Malaria Research Unit; The World Health Organization Regional Office for the Western Pacific philippines; GlaxoSmithKline plc.; PATH; Mahidol University; Nuffield Department of Clinical Medicine
15-Feb-2014Safety and pharmacokinetics of intravenous zanamivir treatment in hospitalized adults with influenza: An open-label, multicenter, single-arm, Phase II studyFrancisco M. Marty; Choy Y. Man; Charles Van Der Horst; Bruno Francois; Denis Garot; Rafael Máňez; Visanu Thamlikitkul; José A. Lorente; Francisco Álvarez-Lerma; David Brealey; Henry H. Zhao; Steve Weller; Phillip J. Yates; Amanda F. Peppercorn; Brigham and Women's Hospital; Dept. of Clinical Development; GlaxoSmithKline, USA; University of North Carolina School of Medicine; Hopital Dupuytren; Hopital Bretonneau; Hospital Universitari de Bellvitge; Parc de Salut Mar; Hospital Universitario de Getafe; Mahidol University; UCL; GlaxoSmithKline plc.
29-Jul-2016Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)J. Bousquet; J. Farrell; G. Crooks; P. Hellings; E. H. Bel; M. Bewick; N. H. Chavannes; J. Correia De Sousa; A. A. Cruz; T. Haahtela; G. Joos; N. Khaltaev; J. Malva; A. Muraro; M. Nogues; S. Palkonen; S. Pedersen; C. Robalo-Cordeiro; B. Samolinski; T. Strandberg; A. Valiulis; A. Yorgancioglu; T. Zuberbier; A. Bedbrook; W. Aberer; M. Adachi; A. Agusti; C. A. Akdis; M. Akdis; J. Ankri; A. Alonso; I. Annesi-Maesano; I. J. Ansotegui; J. M. Anto; S. Arnavielhe; H. Arshad; C. Bai; I. Baiardini; C. Bachert; A. K. Baigenzhin; C. Barbara; E. D. Bateman; B. Beghé; A. Ben Kheder; K. S. Bennoor; M. Benson; K. C. Bergmann; T. Bieber; C. Bindslev-Jensen; L. Bjermer; H. Blain; F. Blasi; A. L. Boner; M. Bonini; S. Bonini; S. Bosnic-Anticevitch; L. P. Boulet; R. Bourret; P. J. Bousquet; F. Braido; A. H. Briggs; C. E. Brightling; J. Brozek; R. Buhl; P. G. Burney; A. Bush; F. Caballero-Fonseca; D. Caimmi; M. A. Calderon; CHU Montpellier; MACVIA-LR; Vieillissement et Maladies Chroniques. Approches Epidemiologiques et de Sante Publique; Universite de Versailles Saint-Quentin-en-Yvelines; Department of Health; National Health Service; KU Leuven; European Academy of Allergy and Clinical Immunology; Academic Medical Centre, University of Amsterdam; European Respiratory Society; iQ4U Consultants Ltd; Leiden University Medical Center - LUMC; Global Alliance Against Chronic Respiratory Diseases (GARD); International Primary Care Respiratory Group; Universidade do Minho, Escola de Ciencias da Saude; Universidade Federal da Bahia; GARD Executive Committee; EIP on AHA Commitment for Action; Skin and Allergy Hospital; University Hospital of Ghent; Universidade de Coimbra, Faculdade de Medicina; AgeingatCoimbra Reference Site; Azienda Ospedaliera Di Padova; Caisse Assurance Retraite et Santé Au Travail Languedoc-Roussillon (CARSAT-LR); EFA European Federation of Allergy and Airways Diseases Patients' Associations; Syddansk Universitet; Centro Hospitalar e Universitario de Coimbra; Medical University of Warsaw; Helsingin Yliopisto; Oulun Yliopisto; European Union; Vilniaus universitetas; European Academy of Paediatrics (EAP/UEMS-SP); Celal Bayar Universitesi; Turkish Thoracic Society; Charité – Universitätsmedizin Berlin; Secretary General of the Global Allergy and Asthma European Network (GA2LEN); Medizinische Universitat Graz; International University of Health and Welfare; Universitat de Barcelona; Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias; University of Zurich; Inserm; Clinica Quiron; Centre de Recerca en Epidemiologia Ambiental, Barcelona; Hospital del Mar; CIBER Epidemiologia Y Salud Publica; Universitat Pompeu Fabra Barcelona; Digi Health; David Hide Asthma and Allergy Research Centre; Chinese Medical Association; Ospedale Policlinico San Martino; EuroAsian Respiratory Society; Faculdade de Medicina, Universidade de Lisboa; University of Cape Town; Universita degli Studi di Modena e Reggio Emilia; Universite de Tunis El Manar, Hopital Abderrahmene Mami; National Institute of Diseases of the Chest and Hospital; Linköpings universitet; Universität Bonn; Odense Universitetshospital; Skånes universitetssjukhus; Centre Européen de Recherche sur le Mouvement Humain, Université de Montpellier; Università degli Studi di Milano; Università degli Studi di Verona; Università degli Studi di Roma La Sapienza; Università degli Studi della Campania Luigi Vanvitelli; The University of Sydney; Université Laval; University of Glasgow; University Hospitals of Leicester NHS Trust; University of Leicester; McMaster University, Faculty of Health Sciences; Johannes Gutenberg Universität Mainz; National Heart and Lung Institute; GlaxoSmithKline plc.; Medical Research Council; Royal Brompton Hospital; Centro Medico Docente La Trinidad; University of Liverpool; Universidade Federal de Minas Gerais; Région Languedoc Roussillon; Oslo University Hospital; Allergy & Asthma Associates of Southern California; Regional Ministry of Equality; University of South Florida, Tampa; Universidad Simón Bolívar; Asma e Immunologia; Panepistimio Kritis; Capital Institute of Pediatrics; Tbilisi State Medical University; Pulmonolory Research Institute FMBA; Latvian Psychiatric Association; Nova Southeastern University; Imperial College London; Karolinska Institutet; Technical University of Munich; CHU Strasbourg; EUREGHA; University of Edinburgh; Universitatea de Medicina si Farmacie Iuliu Hatieganu din Cluj-Napoca; Kronikgune; Sorbonne Universite
1-Jan-2014Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): A multicentre, double-blind, randomised, phase 2b dose-selection studyAlejandro Llanos-Cuentas; Marcus V. Lacerda; Ronnatrai Rueangweerayut; Srivicha Krudsood; Sandeep K. Gupta; Sanjay K. Kochar; Preetam Arthur; Nuttagarn Chuenchom; Jörg J. Möhrle; Stephan Duparc; Cletus Ugwuegbulam; Jörg Peter Kleim; Nick Carter; Justin A. Green; Lynda Kellam; Universidad Peruana Cayetano Heredia; Fundacao de Medicina Tropical do Amazonas; Mae Sot General Hospital; Mahidol University; MV Hospital and Research Centre; Sardar Patel Medical College; Sri Ramachandra Medical College & Research Institute (Deemed University); Medicines for Malaria Venture; GlaxoSmithKline plc.
18-Feb-2016Tafenoquine treatment of Plasmodium vivax malaria: Suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trialPamela L. St Jean; Zhengyu Xue; Nick Carter; Gavin C.K.W. Koh; Stephan Duparc; Maxine Taylor; Claire Beaumont; Alejandro Llanos-Cuentas; Ronnatrai Rueangweerayut; Srivicha Krudsood; Justin A. Green; Justin P. Rubio; PAREXEL International; GlaxoSmithKline plc.; Medicines for Malaria Venture; Universidad Peruana Cayetano Heredia; Mae Sot General Hospital; Mahidol University; University of Melbourne